Condylox is a Topical Gel in the Human Prescription Drug category. It is labeled and distributed by Allergan, Inc.. The primary component is Podofilox.
| Product ID | 0023-6118_01b8d25b-e7d0-43eb-b24e-6ef9a9a8072a |
| NDC | 0023-6118 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Condylox |
| Generic Name | Podofilox |
| Dosage Form | Gel |
| Route of Administration | TOPICAL |
| Marketing Start Date | 1997-03-13 |
| Marketing Category | NDA / NDA |
| Application Number | NDA020529 |
| Labeler Name | Allergan, Inc. |
| Substance Name | PODOFILOX |
| Active Ingredient Strength | 5 mg/g |
| Pharm Classes | Decreased Mitosis [PE] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 1997-03-13 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA020529 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | GM |
| Marketing Start Date | 1997-03-13 |
| Ingredient | Strength |
|---|---|
| PODOFILOX | 5 mg/g |
| SPL SET ID: | 032e4bcb-b1ed-4029-b2a6-e92f3bf5cc37 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0023-6118 | Condylox | podofilox |
| 0574-0611 | PODOFILOX | PODOFILOX |
| 0591-3204 | Podofilox | Podofilox |
| 63629-8832 | Podofilox | Podofilox |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() CONDYLOX 73600709 1418919 Live/Registered |
OCLASSEN PHARMACEUTICALS, INC. 1986-05-27 |